K970029 is an FDA 510(k) clearance for the KEELER SPECTRA INDIRECT OPHTHALMOSCOPE. Classified as Ophthalmoscope, Battery-powered (product code HLJ), Class II - Special Controls.
Submitted by Keeler Instruments, Inc. (Broomall, US). The FDA issued a Cleared decision on April 2, 1997 after a review of 89 days - a notably fast clearance cycle.
This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.1570 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.